MY106984A - Antiviral or antibacterial composition and method of use. - Google Patents

Antiviral or antibacterial composition and method of use.

Info

Publication number
MY106984A
MY106984A MYPI89000670A MYPI19890670A MY106984A MY 106984 A MY106984 A MY 106984A MY PI89000670 A MYPI89000670 A MY PI89000670A MY PI19890670 A MYPI19890670 A MY PI19890670A MY 106984 A MY106984 A MY 106984A
Authority
MY
Malaysia
Prior art keywords
antiviral
composition
disclosed
antibacterial composition
forms
Prior art date
Application number
MYPI89000670A
Inventor
Witold Kiczka Dr
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1988/001785 external-priority patent/WO1989011294A1/en
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of MY106984A publication Critical patent/MY106984A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A COMPOSITION HAVING ANTIVIRAL AND ANTIBACTERIAL EFFECTS IS DISCLOSED WHICH COMPRISES THE DIMERIC FORMS OF ENZYMES SELECTED FROM THE GROUP CONSISTING OF LYSOZYME AND RIBONUCLEASE AND A PHARMACEUTICALLY ACCEPTABLE CARRIER. THESE DIMERIC FORMS ARE MORE EFFECTIVE IN TREATING A VARIETY OF HUMAN AND ANIMAL DISEASES BECAUSE THEY ARE MUCH LESS CYTOTOXIC THAN THE MONOMERIC FORMS OF THE ENZYME. A METHOD FOR THE USE OF THESE COMPOSITIONS IS ALSO DISCLOSED WHICH COMPRISES APPLYING AN EFFECTIVE AMOUNT OF THE COMPOSITION TO THE INFECTED AREA.
MYPI89000670A 1988-05-26 1989-05-17 Antiviral or antibacterial composition and method of use. MY106984A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
MY106984A true MY106984A (en) 1995-08-30

Family

ID=35006604

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89000670A MY106984A (en) 1988-05-26 1989-05-17 Antiviral or antibacterial composition and method of use.

Country Status (4)

Country Link
KR (1) KR930004599B1 (en)
AR (1) AR240542A1 (en)
MY (1) MY106984A (en)
UA (1) UA26326C2 (en)

Also Published As

Publication number Publication date
KR900701307A (en) 1990-12-01
KR930004599B1 (en) 1993-06-01
AR240542A1 (en) 1990-05-31
UA26326C2 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
MW390A1 (en) Antiviral or antibacterial compound and method of use
MY110734A (en) Improvements in or relating to dioic acids.
AU6649996A (en) Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
AU7211787A (en) Intraocular dosage compositions and method of use
MX9702932A (en) L-ribofuranosyl nucleosides.
WO1996023065A3 (en) Inhibition of neovascularization using vegf-specific oligonucleotides
CA2212537A1 (en) Therapeutic inhibitor of vascular smooth muscle cells
AU693833B2 (en) Products containing G-CSF and TNF binding protein
JO1589B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
ZA929947B (en) Method of imparting antimicrobial activity to an opthalmic composition.
EP0813409A4 (en) Treatment of cytokine growth factor caused disorders
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
MY106984A (en) Antiviral or antibacterial composition and method of use.
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
GR1001006B (en) Method for preparating and using antimicrobiac or antibacterial compositions
GB8924527D0 (en) Method and composition for preventing or inhibiting plant virus diseases
AU2314488A (en) Anthelmintic acylhydrazones, method of use and compositions
MX9307639A (en) METHOD FOR TREATING VIRAL INFECTIONS WITH CONJUNCTIVE THERAPY WITH COMPOUNDS SIMILAR TO ACICLOVIR AND AN ANALOGUE OF 2'-VIRIL SUBSTITUTED NUCLEOSIDE.
AU1966988A (en) Ophthalmic agent and related compositions and method for treatment of the cornea
MY104932A (en) Immunomodulatory azaspiranes
MX9605327A (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration.